JPMorgan prices $785K Accelerated Barrier Notes due 2031
JPMorgan Chase Financial Company LLC priced $785,000 of uncapped Accelerated Barrier Notes linked to the S&P 500® Futures Excess Return Index due June 30, 2031, with pricing on June 25, 2026 and expected settlement on or about June 30, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC priced $785,000 of uncapped Accelerated Barrier Notes linked to the S&P 500® Futures Excess Return Index due June 30, 2031, with pricing on June 25, 2026 and expected settlement on or about June 30, 2026. The notes pay at maturity an uncapped return equal to 1.87 times any Index appreciation but expose holders to full principal loss if the Final Value falls below a 70.00% Barrier of the Initial Value. The notes are unsecured obligations of JPMorgan Financial and are fully and unconditionally guaranteed by JPMorgan Chase & Co. The per-note original issue price was $1,000 (proceeds to issuer per note $959.3710), the estimated value at pricing was $925.90 per $1,000 note, and the CUSIP is 46661ALN8. Investors receive no periodic interest, face issuer and guarantor credit risk, potential negative roll and futures-market risks, limited liquidity, and tax-treatment uncertainty discussed in the supplement.
Insights
Uncapped 1.87x upside with a 70% barrier but significant downside and liquidity constraints.
The notes provide leveraged upside through an Upside Leverage Factor of 1.87 on positive Index returns and return principal only if the Final Value stays at or above 70.00% of Initial Value; below that barrier investors suffer pro rata losses. The structure uses futures excess-return exposure, so negative roll returns and futures-market distortions can materially depress Index performance over time.
Secondary-market liquidity is limited because the notes will not be exchange-listed; JPMS may provide quotes but any repurchase price will likely be lower than the original issue price. Cash-flow treatment is issuer/guarantor-dependent and tax characterization may be complex; consult advisers for suitability.
Tax treatment is uncertain; counsel treated notes as "open transactions" but IRS could disagree.
Special tax counsel opines the notes may be treated as open transactions and not as debt, which would produce long-term capital treatment if held over one year. This opinion depends on current law and assumptions; the IRS or a court might reach a different conclusion.
Section 871(m) analysis concluded the notes should not be subject to dividend-equivalent withholding for non-U.S. holders under current determinations, but this determination is not binding on the IRS. Holders should consult tax advisers regarding accrual issues and potential retrospective guidance.
Key Figures
Key Terms
S&P 500® Futures Excess Return Index financial
negative roll return market
hybrid instrument exemption regulatory
open transactions tax
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the key payout mechanics of JPMorgan Chase (JPM) Accelerated Barrier Notes due 2031?
How much was raised and what were net proceeds to the issuer for these JPM notes?
What was the estimated value per note at pricing and how does it compare to the issue price?
When are the pricing and settlement dates for these JPMorgan structured notes (CUSIP 46661ALN8)?
What major risks should investors in JPMorgan Chase structured notes consider?
AI-generated analysis. How Rhea-AI works. Not financial advice.



